Intravenous Infusion Pumps Market Size, Share & Trends Analysis Report By Product (Volumetric Infusion Pumps, Syringe Infusion Pumps), By Disease Indication (Chemotherapy, Diabetes, Gastroenterology), By Region, And Segment Forecasts, 2025 - 2030

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                    1.2. Segment Definitions
                        1.2.1. Product
                        1.2.2. Disease Indication
                        1.2.3. Regional scope
                        1.2.4. Estimates and forecasts timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased database
                        1.4.2. GVR’s internal database
                        1.4.3. Secondary sources
                        1.4.4. Primary research
                        1.4.5. Details of primary research
                    1.5. Information or Data Analysis
                        1.5.1. Data analysis models
                    1.6. Market Formulation & Validation
                    1.7. Model Details
                    1.8. List of Secondary Sources
                    1.9. List of Primary Sources
                    1.10. Objectives
Chapter 2. Executive Summary
                    2.1. Market Outlook
                    2.2. Segment Outlook
                        2.2.1. Product outlook
                        2.2.2. Disease indication outlook
                        2.2.3. Regional outlook
                    2.3. Competitive Insights
Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent market outlook
                        3.1.2. Related/ancillary market outlook
                    3.2. Market Dynamics
                        3.2.1. Market driver analysis
                        3.2.2. Market restraint analysis
                    3.3. Intravenous Infusion Pumps Market Analysis Tools
                        3.3.1. Industry Analysis - Porter’s
                            3.3.1.1. Supplier power
                            3.3.1.2. Buyer power
                            3.3.1.3. Substitution threat
                            3.3.1.4. Threat of new entrant
                            3.3.1.5. Competitive rivalry
                        3.3.2. PESTEL Analysis
                            3.3.2.1. Political landscape
                            3.3.2.2. Technological landscape
                            3.3.2.3. Economic landscape
                    3.4. Intravenous Infusion Pumps Market: Pipeline Analysis
Chapter 4. Intravenous Infusion Pumps Market: Product Estimates & Trend Analysis
                    4.1. Product Segment Dashboard
                    4.2. Intravenous Infusion Pumps Market: Product Movement Analysis
                    4.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
                    4.4. Volumetric Infusion Pumps
                        4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.5. Syringe Infusion Pumps
                        4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.6. Insulin Infusion Pumps
                        4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.7. Enteral Infusion Pumps
                        4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.8. Ambulatory Infusion Pumps
                        4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.9. Patient-Controlled Analgesia Infusion Pumps
                        4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.10. Implantable Infusion Pumps
                        4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    4.11. Others
                        4.11.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Intravenous Infusion Pumps Market: Disease Indication Estimates & Trend Analysis
                    5.1. Disease Indication Segment Dashboard
                    5.2. Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
                    5.3. Global Intravenous Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)
                    5.4. Chemotherapy
                        5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.5. Diabetes
                        5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.6. Gastroenterology
                        5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.7. Analgesia/Pain Management
                        5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.8. Pediatrics/Neonatology
                        5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.9. Hematology
                        5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
                    5.10. Others
                        5.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Intravenous Infusion Pumps Market: Regional Estimates & Trend Analysis
                    6.1. Regional Market Dashboard
                    6.2. Regional Market Share Analysis, 2024 & 2030
                    6.3. Intravenous infusion pumps market by Region: Key Takeaways
                    6.4. North America
                        6.4.1. U.S.
                            6.4.1.1. Key country dynamics
                            6.4.1.2. Regulatory framework/ reimbursement structure
                            6.4.1.3. Competitive scenario
                            6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.2. Canada
                            6.4.2.1. Key country dynamics
                            6.4.2.2. Regulatory framework/ reimbursement structure
                            6.4.2.3. Competitive scenario
                            6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
                        6.4.3. Mexico
                            6.4.3.1. Key country dynamics
                            6.4.3.2. Regulatory framework/ reimbursement structure
                            6.4.3.3. Competitive scenario
                            6.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
                    6.5. Europe
                        6.5.1. UK
                            6.5.1.1. Key country dynamics
                            6.5.1.2. Regulatory framework/ reimbursement structure
                            6.5.1.3. Competitive scenario
                            6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.2. Germany
                            6.5.2.1. Key country dynamics
                            6.5.2.2. Regulatory framework/ reimbursement structure
                            6.5.2.3. Competitive scenario
                            6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.3. France
                            6.5.3.1. Key country dynamics
                            6.5.3.2. Regulatory framework/ reimbursement structure
                            6.5.3.3. Competitive scenario
                            6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.4. Italy
                            6.5.4.1. Key country dynamics
                            6.5.4.2. Regulatory framework/ reimbursement structure
                            6.5.4.3. Competitive scenario
                            6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.5. Spain
                            6.5.5.1. Key country dynamics
                            6.5.5.2. Regulatory framework/ reimbursement structure
                            6.5.5.3. Competitive scenario
                            6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.6. Denmark
                            6.5.6.1. Key country dynamics
                            6.5.6.2. Regulatory framework/ reimbursement structure
                            6.5.6.3. Competitive scenario
                            6.5.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.7. Sweden
                            6.5.7.1. Key country dynamics
                            6.5.7.2. Regulatory framework/ reimbursement structure
                            6.5.7.3. Competitive scenario
                            6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
                        6.5.8. Norway
                            6.5.8.1. Key country dynamics
                            6.5.8.2. Regulatory framework/ reimbursement structure
                            6.5.8.3. Competitive scenario
                            6.5.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
                    6.6. Asia Pacific
                        6.6.1. China
                            6.6.1.1. Key country dynamics
                            6.6.1.2. Regulatory framework/ reimbursement structure
                            6.6.1.3. Competitive scenario
                            6.6.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.2. Japan
                            6.6.2.1. Key country dynamics
                            6.6.2.2. Regulatory framework/ reimbursement structure
                            6.6.2.3. Competitive scenario
                            6.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.3. India
                            6.6.3.1. Key country dynamics
                            6.6.3.2. Regulatory framework/ reimbursement structure
                            6.6.3.3. Competitive scenario
                            6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.4. Australia
                            6.6.4.1. Key country dynamics
                            6.6.4.2. Regulatory framework/ reimbursement structure
                            6.6.4.3. Competitive scenario
                            6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.5. South Korea
                            6.6.5.1. Key country dynamics
                            6.6.5.2. Regulatory framework/ reimbursement structure
                            6.6.5.3. Competitive scenario
                            6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
                        6.6.6. Thailand
                            6.6.6.1. Key country dynamics
                            6.6.6.2. Regulatory framework/ reimbursement structure
                            6.6.6.3. Competitive scenario
                            6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
                    6.7. Latin America
                        6.7.1. Brazil
                            6.7.1.1. Key country dynamics
                            6.7.1.2. Regulatory framework/ reimbursement structure
                            6.7.1.3. Competitive scenario
                            6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
                        6.7.2. Argentina
                            6.7.2.1. Key country dynamics
                            6.7.2.2. Regulatory framework/ reimbursement structure
                            6.7.2.3. Competitive scenario
                            6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
                    6.8. MEA
                        6.8.1. South Africa
                            6.8.1.1. Key country dynamics
                            6.8.1.2. Regulatory framework/ reimbursement structure
                            6.8.1.3. Competitive scenario
                            6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.2. Saudi Arabia
                            6.8.2.1. Key country dynamics
                            6.8.2.2. Regulatory framework/ reimbursement structure
                            6.8.2.3. Competitive scenario
                            6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.3. UAE
                            6.8.3.1. Key country dynamics
                            6.8.3.2. Regulatory framework/ reimbursement structure
                            6.8.3.3. Competitive scenario
                            6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
                        6.8.4. Kuwait
                            6.8.4.1. Key country dynamics
                            6.8.4.2. Regulatory framework/ reimbursement structure
                            6.8.4.3. Competitive scenario
                            6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
                    7.1. Recent Developments & Impact Analysis, By Key Market Participants
                    7.2. Company/Competition Categorization
                    7.3. Vendor Landscape
                        7.3.1. Key company heat map analysis, 2024
                    7.4. Company Profiles
                        7.4.1. Baxter
                            7.4.1.1. Company overview
                            7.4.1.2. Financial performance
                            7.4.1.3. Product benchmarking
                            7.4.1.4. Strategic initiatives
                        7.4.2. B. Braun Medical Inc.
                            7.4.2.1. Company overview
                            7.4.2.2. Financial performance
                            7.4.2.3. Product benchmarking
                            7.4.2.4. Strategic initiatives
                        7.4.3. Medtronic
                            7.4.3.1. Company overview
                            7.4.3.2. Financial performance
                            7.4.3.3. Product benchmarking
                            7.4.3.4. Strategic initiatives
                        7.4.4. Micrel Medical Devices SA
                            7.4.4.1. Company overview
                            7.4.4.2. Financial performance
                            7.4.4.3. Product benchmarking
                            7.4.4.4. Strategic initiatives
                        7.4.5. Boston Scientific Corporation
                            7.4.5.1. Company overview
                            7.4.5.2. Financial performance
                            7.4.5.3. Product benchmarking
                            7.4.5.4. Strategic initiatives
                        7.4.6. Cardinal Health
                            7.4.6.1. Company overview
                            7.4.6.2. Financial performance
                            7.4.6.3. Product benchmarking
                            7.4.6.4. Strategic initiatives
                        7.4.7. Fresenius Kabi AG
                            7.4.7.1. Company overview
                            7.4.7.2. Financial performance
                            7.4.7.3. Product benchmarking
                            7.4.7.4. Strategic initiatives
                        7.4.8. ICU Medical, Inc.
                            7.4.8.1. Company overview
                            7.4.8.2. Financial performance
                            7.4.8.3. Product benchmarking
                            7.4.8.4. Strategic initiatives
                        7.4.9. F. Hoffmann-La Roche Ltd
                            7.4.9.1. Company overview
                            7.4.9.2. Financial performance
                            7.4.9.3. Product benchmarking
                            7.4.9.4. Strategic initiatives
                        7.4.10. Tandem Diabetes Care, Inc.
                            7.4.10.1. Company overview
                            7.4.10.2. Financial performance
                            7.4.10.3. Product benchmarking
                            7.4.10.4. Strategic initiatives
                        7.4.11. Terumo Corporation
                            7.4.11.1. Company overview
                            7.4.11.2. Financial performance
                            7.4.11.3. Product benchmarking
                            7.4.11.4. Strategic initiatives
                        7.4.12. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
                            7.4.12.1. Company overview
                            7.4.12.2. Financial performance
                            7.4.12.3. Product benchmarking
                            7.4.12.4. Strategic initiatives
                        7.4.13. Moog Inc.
                            7.4.13.1. Company overview
                            7.4.13.2. Financial performance
                            7.4.13.3. Product benchmarking
                            7.4.13.4. Strategic initiatives
                        7.4.14. IRadimed Corporation
                            7.4.14.1. Company overview
                            7.4.14.2. Financial performance
                            7.4.14.3. Product benchmarking
                            7.4.14.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 Global intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
Table 3 Global intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 4 Global intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 5 North America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 6 North America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 7 North America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 8 U.S. intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 10 Canada intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 11 Canada intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 12 Mexico intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 13 Mexico surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
Table 14 Europe intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 15 Europe intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 16 Europe intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 17 UK intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 18 UK intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 19 Germany intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 20 Germany intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 21 France intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 22 France intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 23 Italy intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 24 Italy intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 25 Spain intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 26 Spain intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 27 Denmark intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 28 Denmark intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 29 Sweden intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 30 Sweden intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 31 Norway intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 32 Norway intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 33 Asia Pacific intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 34 Asia Pacific intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 35 Asia Pacific intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 36 China intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 37 China intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 38 Japan intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 39 Japan intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 40 India intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 41 India intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 42 Australia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 43 Australia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 44 South Korea intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 45 South Korea intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 46 Thailand intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 47 Thailand intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 48 Latin America intravenous infusion pumps market, by country, 2018 - 2030 (USD Million)
Table 49 Latin America intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 50 Latin America laparoscopic ablation market, by disease indication, 2018 - 2030 (USD Million)
Table 51 Latin America percutaneous ablation market, by disease indication, 2018 - 2030 (USD Million)
Table 52 Latin America intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 53 Brazil intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 54 Brazil surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
Table 55 Argentina intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 56 Argentina surgical ablation market, by disease indication, 2018 - 2030 (USD Million)
Table 57 MEA intravenous infusion pumps market, by region, 2018 - 2030 (USD Million)
Table 58 MEA intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 59 MEA intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 60 South Africa intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 61 South Africa intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 63 Saudi Arabia intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 64 UAE intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 65 UAE intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)
Table 66 Kuwait intravenous infusion pumps market, by product, 2018 - 2030 (USD Million)
Table 67 Kuwait intravenous infusion pumps market, by disease indication, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Intravenous infusion pumps market: market outlook
Fig. 10 Intravenous infusion pumps competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 Intravenous infusion pumps market driver impact
Fig. 16 Intravenous infusion pumps market restraint impact
Fig. 17 Intravenous infusion pumps market strategic initiatives analysis
Fig. 18 Intravenous infusion pumps market: Product movement analysis
Fig. 19 Intravenous infusion pumps market: Product outlook and key takeaways
Fig. 20 Volumetric infusion pumps estimates and forecast, 2018 - 2030
Fig. 21 Syringe infusion pumps estimates and forecast, 2018 - 2030
Fig. 22 Insulin infusion pumps estimates and forecast, 2018 - 2030
Fig. 23 Enteral infusion pumps estimates and forecast, 2018 - 2030
Fig. 24 Ambulatory infusion pumps estimates and forecast, 2018 - 2030
Fig. 25 Patient-controlled analgesia infusion pumps estimates and forecast, 2018 - 2030
Fig. 26 Implantable infusion pumps estimates and forecast, 2018 - 2030
Fig. 27 Others estimates and forecast, 2018 - 2030
Fig. 28 Intravenous infusion pumps market: Disease indication movement analysis
Fig. 29 Intravenous infusion pumps market: Disease indication outlook and key takeaways
Fig. 30 Chemotherapy estimates and forecast, 2018 - 2030
Fig. 31 Diabetes estimates and forecast, 2018 - 2030
Fig. 32 Gastroenterology estimates and forecast, 2018 - 2030
Fig. 33 Analgesia/pain management estimates and forecast, 2018 - 2030
Fig. 34 Pediatrics/neonatology estimates and forecast, 2018 - 2030
Fig. 35 Hematology estimates and forecast, 2018 - 2030
Fig. 36 Others estimates and forecast, 2018 - 2030
Fig. 37 Global intravenous infusion pumps market: Regional movement analysis
Fig. 38 Global intravenous infusion pumps market: Regional outlook and key takeaways
Fig. 39 North America market estimates and forecasts, 2018 - 2030
Fig. 40 U.S. market estimates and forecasts, 2018 - 2030
Fig. 41 Canada market estimates and forecasts, 2018 - 2030
Fig. 42 Mexico market estimates and forecasts, 2018 - 2030
Fig. 43 Europe market estimates and forecasts, 2018 - 2030
Fig. 44 UK market estimates and forecasts, 2018 - 2030
Fig. 45 Germany market estimates and forecasts, 2018 - 2030
Fig. 46 France market estimates and forecasts, 2018 - 2030
Fig. 47 Italy market estimates and forecasts, 2018 - 2030
Fig. 48 Spain market estimates and forecasts, 2018 - 2030
Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
Fig. 50 Sweden market estimates and forecasts, 2018 - 2030
Fig. 51 Norway market estimates and forecasts, 2018 - 2030
Fig. 52 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 53 China market estimates and forecasts, 2018 - 2030
Fig. 54 Japan market estimates and forecasts, 2018 - 2030
Fig. 55 India market estimates and forecasts, 2018 - 2030
Fig. 56 Australia market estimates and forecasts, 2018 - 2030
Fig. 57 South Korea market estimates and forecasts, 2018 - 2030
Fig. 58 Thailand market estimates and forecasts, 2018 - 2030
Fig. 59 Latin America market estimates and forecasts, 2018 - 2030
Fig. 60 Brazil market estimates and forecasts, 2018 - 2030
Fig. 61 Argentina market estimates and forecasts, 2018 - 2030
Fig. 62 Middle East and Africa market estimates and forecasts, 2018 - 2030
Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
Fig. 64 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 65 UAE market estimates and forecasts, 2018 - 2030
Fig. 66 Kuwait market estimates and forecasts, 2018 - 2030